Zhou et al. reported that activating 7 nicotinic acetylcholine receptor, the mediator of cholinergic anti-inflammation pathway, suppressed the release of TNF-α and IL-6 in a mouse NASH model. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.